PranaX Corporation ( an emerging regenerative medicine biotechnology company, today announced that it has licensed exosome technology from The University of Texas MD Anderson Cancer Center to develop ...

Maui Mayor Richard Bissen urged the police commission to investigate Chief John Pelletier and place him on leave over the ...

We are focused on the potential FDA approval for CARDAMYST and the opportunity to help the millions of patients suffering from PSVT,” said ...

MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, March 13, 2025 (GLOBE NEWSWIRE) -- Lifeward Ltd., (Nasdaq: LFWD) (“Lifeward” or the “Company”), a ...

The drug, also called Relugolix, blocks signals from the brain that tell the ovaries to make oestrogen, a hormone that fuels the growth of endometriosis tissue, according to Prof Ying Cheong, ...

Unlike current injectable treatments, the new drug can be taken at home and works faster. The daily, long-term pill blocks specific hormones and can significantly reduce heavy bleeding, easing ...

Spineart and eCential Robotics today announced the receipt of FDA 510(k) clearance for the use of an application for robotic ...

The combination drug could help around 1,000 women every year in England who suffer from the debilitating condition. | ITV National News ...

Johnson & Johnson MedTech announced today that the FDA cleared its Monarch Quest technology for robotic-assisted bronchoscopy ...

The MagDI System is a self-aligning, incisionless, sutureless and staple-free technology for surgical linkage.

The combination drug could provide relief for around 1,000 women in England each year who suffer from this debilitating ...

The FDA granted fast track designation to ATSN-201 for the treatment of X-linked retinoschisis, according to a press release from Atsena Therapeutics.